openPR Logo
Press release

Epinephrine Market Report Explored in Latest Research

02-06-2018 03:22 PM CET | Health & Medicine

Press release from: Transparency Market Research

Epinephrine or adrenaline is a hormone secreted by adrenal glands in the blood stream. It is one of the two common hormones (the other being glucagon) that is responsible for glycogen breakdown. Secretion of epinephrine is characterized by the presence of extreme emotions such as anxiety or anger thereby resulting in elevated levels of blood pressure along with increased muscle strength and high sugar metabolism.

Under strenuous conditions signals are transmitted to brain and brain in turn sends nerve impulses to the adrenal glands in the kidneys and result in the release or secretion of epinephrine. The presence of this hormone is essential for the body to maintain cardiovascular homeostasis as epinephrine can divert blood to tissues under stress. Epinephrine is used as a vasoconstrictor in shock, as a stimulant during cardiac arrest and as an antispasmodic and bronchodilator in bronchial asthma.

Obtain Report Details @ https://www.transparencymarketresearch.com/epinephrine-market.html

During cardiac arrest, there is a need for maximum amount of blood flow in the coronary artery and this is facilitated when epinephrine is injected into an intravenous solution. Epinephrine has effects on various parts of the body such as liver, skin, heart and lungs. For instance, in lungs epinephrine causes the relaxation of smooth muscles of lungs. Patients suffering from asthma have constricted lung passages that are prone to inflammation and swelling. This swelling result in coughing, wheezing, shortness of breath and due to inhalation of epinephrine in small doses causes the widening of the bronchial tubes thereby allowing the air to pass through and provides short term relief.

Epinephrine injections are commonly used against life threatening allergic reactions caused by medications, insect bites and stings. Epinephrine injections are available as prefilled automatic injection device with the hormone in the liquid form. Epinephrine is a class of medications called as alpha and beta adrenergic agonists and these medications work by tightening the blood vessels and by relaxing the muscles in the airways.

The direction for preparing and use of the injectors is dependent on different brands available in the market. This injection is usually administered on the thighs and effects of this medication are fast and quick but not long lasting. Epinephrine has both mild and serious side effects such as high blood pressure, severe headache, blurred vision, chest pain, uneven heartbeats, dizziness, nausea and vomiting.

The market for epinephrine auto-injector market exhibits tremendous growth potential owing to several technological advances towards development of innovative epinephrine injectors. Epinephrine auto injectors market can be analyzed on the basis of the product penetration and availability across the four major geographical regions namely North America, Europe, Asia-Pacific and RoW. Adrenaclick, EpiPen Auto-Injector, Adrenalin Chloride Solution and EpiPen Jr. Auto-Injector, epinephrine lidocaine hydrochloride are some of the brands of epinephrine autoinjectors.

Download Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2466

Some of the major factors favoring the growth of this market are increasing number of patient population susceptible to several allergic reactions along with increased focus of the market players towards development of chlorofluorocarbon (CFC) free epinephrine auto-injectors. This is majorly due to the ban on the use of CFC as a propellant inhaler by the U.S. Government.

In addition, continuous product modifications, increased need and demand of automatic injection devices further propel the growth and development of epinephrine auto injectors market. On the contrary, the side effects caused by epinephrine medications pose a challenge to the growth of the market.

Pre-Book Full Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=2466<ype=S

Owing to the potential side effects (dizziness, shortness of breath and severe headache) of epinephrine therapy, doctors recommend or prescribe other alternative pharmacotherapy and immunotherapy against allergic reactions. The key market players operating in this market are Abbott Laboratories, Lincoln Medical, Ltd., Mylan, Inc., Sanofi SA, Amedra Pharmaceuticals LLC and ALK Abello A/S.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Epinephrine Market Report Explored in Latest Research here

News-ID: 933781 • Views:

More Releases from Transparency Market Research

Latin America Baby Feeding Products Market to See 3.6% CAGR Through 2031 Amid Product Innovation and E-commerce Expansion
Latin America Baby Feeding Products Market to See 3.6% CAGR Through 2031 Amid Pr …
The Latin America baby feeding products market has witnessed substantial growth and is projected to continue expanding. Valued at US$ 518.6 million in 2022, this market is anticipated to grow at a CAGR of 3.6% from 2023 to 2031, reaching an estimated US$ 706.2 million by 2031. Key factors such as rising disposable income, greater awareness of child health, and increasing numbers of working women are fueling demand for baby
Floating Nuclear Power Plant EPC Industry to Grow from $327 Mn in 2023 to $1.0 Bn by 2034
Floating Nuclear Power Plant EPC Industry to Grow from $327 Mn in 2023 to $1.0 B …
The global Floating Nuclear Power Plant (FNPP) Engineering, Procurement, and Construction (EPC) market is poised for significant growth, driven by the increasing demand for reliable energy sources in remote and offshore areas. Valued at US$ 327.0 million in 2023, the market is projected to grow at a CAGR of 9.3% from 2024 to 2034, reaching a total of US$ 1.0 billion by the end of the forecast period. Download Sample Report
Biohydrogen Market to Expand from $73.4 Million in 2023 to $146.7 Million by 2034
Biohydrogen Market to Expand from $73.4 Million in 2023 to $146.7 Million by 203 …
The Global Biohydrogen Market (바이오수소 시장) was valued at USD 73.4 million in 2023 and is projected to grow at a CAGR of 6.5%, reaching USD 146.7 million by the end of 2034. This growth is driven by increasing concerns over climate change and dwindling petroleum reserves, which are propelling the demand for sustainable energy alternatives like biohydrogen. Download Sample Report Copy Here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=74581&utm_source=OpenPR_Sandeep&utm_medium=OpenPR Analyst Viewpoint Rising concerns regarding climate change are significantly
North America Hospital Disinfectant Products Market to Reach $5.4 Billion by 2031, Driven by Rising Infection Control Demands
North America Hospital Disinfectant Products Market to Reach $5.4 Billion by 203 …
The North America hospital disinfectant products market is a vital segment of the healthcare industry, particularly in the context of rising healthcare-associated infections (HAIs) and stringent regulatory standards. As of 2022, the market was valued at approximately US$ 3.1 billion, and it is projected to grow at a CAGR of 6.3% from 2023 to 2031, reaching around US$ 5.4 billion by the end of the forecast period. This growth reflects

All 5 Releases


More Releases for Epinephrine

Epinephrine Market Global Outlook and Top Manufacturers 2020
Global Epinephrine Market Research Report published by market insight reports explores the current market outlook in global and key regions from the perspective of Major Players, Countries, Product types and end industries or applications. Historical data from 2014 to 2019 is considered for the analysis and forms the base for the CAGR calculations. The forecasted data is provided from 2020 to 2025 which is derived using primary as well as
Epinephrine Market Report 2018: Segmentation by Type (Epinephrine Auto-injector, …
Global Epinephrine market research report provides company profile for Amphastar, Emerade, Grand Pharma, Harvest Pharmaceuticals, Merit Pharmaceutical, Tianjin Jinyao Group, Mylan Inc, Impax, ALK Abello, Lincoln Medical Ltd, Pfizer and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year
Epinephrine Market Intelligence Report Offers Growth Prospects
Epinephrine or adrenaline is a hormone secreted by adrenal glands in the blood stream. It is one of the two common hormones (the other being glucagon) that is responsible for glycogen breakdown. Secretion of epinephrine is characterized by the presence of extreme emotions such as anxiety or anger thereby resulting in elevated levels of blood pressure along with increased muscle strength and high sugar metabolism. Under strenuous conditions signals are
Global Epinephrine Autoinjector Industry 2016 Market Research Report
The Global Epinephrine Autoinjector Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Epinephrine Autoinjector industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Epinephrine Autoinjector market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status. Request Sample Report Here: http://www.reportbazzar.com/request-sample/?pid=569859&ptitle=Global+Epinephrine+Autoinjector+Industry+2016+Market+Research+Report&req=Sample Secondly, development policies and
Global Epinephrine Autoinjector Market Professional Survey Report 2016
Summary This report Mainly covers the following product types For patients using fixed needle syringes For patients using removable needle syringes The segment applications including Segment regions including (the separated region report can also be offered) USA China Europe South America Japan Africa Get Sample Report @ http://www.reportbazzar.com/request-sample/?pid=601286&ptitle=Global+Epinephrine+Autoinjector+Market+Professional+Survey+Report+2016&req=Sample The players list (Partly, Players you are interested in can also be added) Mylan ALK Abello Amedra Pharmaceuticals Sanofi Adamis Pharmaceuticals Owen Mumford Lineage Therapeutics Inc With no less than 15 top producers. Data including (both global and regions): Market Size (both volume – Unit
Epinephrine Market grows with several technological advances towards development …
Epinephrine or adrenaline is a hormone secreted by adrenal glands in the blood stream. It is one of the two common hormones (the other being glucagon) that is responsible for glycogen breakdown. Secretion of epinephrine is characterized by the presence of extreme emotions such as anxiety or anger thereby resulting in elevated levels of blood pressure along with increased muscle strength and high sugar metabolism. Under strenuous conditions signals are